+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Becton Dickinson and Co
  • Boston Scientific Corp
  • Gel4Med Inc
  • Hospira Inc
  • Johnson & Johnson
  • Medtronic Plc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review provides you with an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better

The profile contains critical company information including:


  • Business description: A detailed description of the company’s operations and business divisions
  • Corporate strategy: Analyst’s summarization of the company’s business strategy
  • SWOT Analysis: A detailed analysis of the company’s strengths, weaknesses, opportunities and threats
  • Company history: Progression of key events associated with the company
  • Major products and services: A list of major products, services and brands of the company
  • Key competitors: A list of key competitors to the company
  • Key employees: A list of the key executives of the company
  • Executive biographies: A brief summary of the executives’ employment history
  • Key operational heads: A list of personnel heading key departments/functions
  • Important locations and subsidiaries: A list and contact details of key locations and subsidiaries of the company
  • Detailed financial ratios for the past five years: The latest financial ratios derived from the annual financial statements published by the company with 5 years history
  • Interim ratios for the last five interim periods: The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history

Highlights


Baxter International Inc (Baxter) is a provider of a range of healthcare products, including dialysis in acute and chronic conditions, sterile intravenous solutions, generic injectable pharmaceuticals, parenteral nutrition therapies, infusion systems and devices, inhaled anaesthetics, and surgical hemostat and sealant products. The company’s products find application in hospitals, rehabilitation centers, kidney dialysis centers, nursing homes, besides patients at home under physician supervision. Baxter distributes products through direct sales force and a network of independent distributors, drug wholesalers, specialty pharmacies and other alternative site providers. The company has operations in the Americas, the Middle East, Africa, Europe and Asia-Pacific. Baxter is headquartered in Deerfield, Illinois, the US.

Baxter International Inc Key Recent Developments


Feb 23, 2022: Baxter Expands Cybersecurity Commitment, Joins Forces With U.S. Cybersecurity and Infrastructure Security Agency (CISA) Led Program
Feb 17, 2022: Baxter reports fourth-quarter and full-year 2021 results
Feb 10, 2022: Baxter to Present at Citi’s 2022 Virtual Healthcare Conference
Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors
Dec 08, 2021: Baxter presents data at ASHP meeting indicating machine learning may enhance infusion pump programming safety

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential is assessed in the profile. Competitive and/or technological threats are highlighted

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs

Note: Some sections may be missing if data is unavailable for the company

FEATURED COMPANIES

  • Becton Dickinson and Co
  • Boston Scientific Corp
  • Gel4Med Inc
  • Hospira Inc
  • Johnson & Johnson
  • Medtronic Plc

Section 1 - About the Company
  • Baxter International Inc - Key Facts
  • Baxter International Inc - Key Employees
  • Baxter International Inc - Key Employee Biographies
  • Baxter International Inc - Major Products and Services
  • Baxter International Inc - History
  • Baxter International Inc - Company Statement
  • Baxter International Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture

Section 2 - Company Analysis
  • Company Overview
  • Baxter International Inc - Business Description
  • Product Category: Acute Therapies
  • Overview
  • Performance
  • Product Category: Advanced Surgery
  • Overview
  • Performance
  • Product Category: BioPharma Solutions
  • Overview
  • Performance
  • Product Category: Clinical Nutrition
  • Overview
  • Performance
  • Product Category: Front Line Care
  • Overview
  • Performance
  • Product Category: Medication Delivery
  • Overview
  • Performance
  • Product Category: Other
  • Overview
  • Performance
  • Product Category: Patient Support Systems
  • Overview
  • Performance
  • Product Category: Pharmaceuticals
  • Overview
  • Performance
  • Product Category: Renal Care
  • Overview
  • Performance
  • Product Category: Surgical Solutions
  • Overview
  • Performance
  • Product Category: Americas
  • Overview
  • Performance
  • Target Markets
  • Product Category: APAC
  • Overview
  • Performance
  • Target Markets
  • Product Category: EMEA
  • Overview
  • Performance
  • Target Markets
  • Product Category: Hillrom
  • Performance
  • Geographical Segment: APAC
  • Target Markets
  • Performance
  • Geographical Segment: EMEA
  • Target Markets
  • Performance
  • Geographical Segment: Latin America and Canada
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • Baxter International Inc - Corporate Strategy
  • Baxter International Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Baxter International Inc - Strengths
  • Baxter International Inc - Weaknesses
  • Baxter International Inc - Opportunities
  • Baxter International Inc - Threats
  • Baxter International Inc - Key Competitors

Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Baxter International Inc, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Baxter International Inc, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • Baxter International Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments
  • Feb 23, 2022: Baxter Expands Cybersecurity Commitment, Joins Forces With U.S. Cybersecurity and Infrastructure Security Agency (CISA) Led Program
  • Feb 17, 2022: Baxter reports fourth-quarter and full-year 2021 results
  • Feb 10, 2022: Baxter to Present at Citi’s 2022 Virtual Healthcare Conference
  • Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors
  • Dec 08, 2021: Baxter presents data at ASHP meeting indicating machine learning may enhance infusion pump programming safety
  • Nov 17, 2021: Baxter Vietnam launches My Kidney Journey portal to support patients with Chronic Kidney Disease
  • Nov 11, 2021: Baxter announces $100 million investment in BioPharma solutions Halle/Westfalen, Germany Sterile fill/finish manufacturing facility
  • Nov 02, 2021: Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference
  • Oct 28, 2021: Baxter reports third-quarter 2021 results
  • Oct 13, 2021: Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference

Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer

List of Tables
  • Baxter International Inc, Key Facts
  • Baxter International Inc, Key Employees
  • Baxter International Inc, Key Employee Biographies
  • Baxter International Inc, Major Products and Services
  • Baxter International Inc, History
  • Baxter International Inc, Subsidiaries
  • Baxter International Inc, Joint Venture
  • Baxter International Inc, Key Competitors
  • Baxter International Inc, Ratios based on current share price
  • Baxter International Inc, Annual Ratios
  • Baxter International Inc, Interim Ratios
  • Baxter International Inc, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Baxter International Inc, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • Baxter International Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • Baxter International Inc, Performance Chart (2017 - 2021)
  • Baxter International Inc, Ratio Charts
  • Baxter International Inc, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Baxter International Inc, Medical Equipment, Deals by Type, 2016 to YTD 2022

Loading
LOADING...

A selection of companies mentioned in this report includes:

  • NxStage Medical Inc
  • Medtronic Plc
  • Johnson & Johnson
  • Hospira Inc
  • Gel4Med Inc
  • Fresenius Medical Care AG & Co KGaA
  • Boston Scientific Corp
  • Becton Dickinson and Co